Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons

Background. Liver diseases progress faster in human immunodeficiency virus (HIV)–hepatitis C virus (HCV)-coinfected persons than HIV-monoinfected persons. The aim of this study was to compare rates of liver fibrosis progression (measured by the aspartate-to-platelet ratio index [APRI]) among HIV-HCV...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2016-01, Vol.62 (2), p.242-249
Hauptverfasser:	Brunet, Laurence, Moodie, Erica E. M., Young, Jim, Cox, Joseph, Hull, Mark, Cooper, Curtis, Walmsley, Sharon, Martel-Laferrière, Valérie, Rachlis, Anita, Klein, Marina B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Retroviral Agents - therapeutic use Antiretroviral drugs Aspartate Aminotransferases - blood Canada Cohort Studies Coinfection - pathology Disease Progression Drug therapy Female Hepatitis Hepatitis C Hepatitis C, Chronic - complications Hepatitis C, Chronic - pathology HIV HIV Infections - complications HIV Infections - drug therapy HIV/AIDS Human immunodeficiency virus Humans Liver Cirrhosis - complications Liver Cirrhosis - pathology Liver diseases Male Middle Aged Platelet Count Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!